Evidence map›Paper›PMID 37533461›Full record

ArticleTobacco prevention & cessation2023

Self-reported depression and anxiety and healthcare professional interactions regarding smoking cessation and nicotine vaping: Findings from 2018 International Tobacco Control Four Country Smoking and Vaping (ITC 4CV) Survey.

Bernadett E Tildy, Ann McNeill, Katherine East, Shannon Gravely, Geoffrey T Fong, K Michael Cummings, Ron Borland, Gary C K Chan, Carmen C W Lim, Coral Gartner and 2 more

Open access · goldAbstract read
In one paragraph

Article in Tobacco prevention & cessation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Bernadett E TildyAddictions Department, King's College London, Addiction Sciences Building, London, United Kingdom.
Ann McNeillAddictions Department, King's College London, Addiction Sciences Building, London, United Kingdom.
Katherine EastAddictions Department, King's College London, Addiction Sciences Building, London, United Kingdom.
Shannon GravelyDepartment of Psychology, University of Waterloo, Waterloo, Canada.
Geoffrey T FongDepartment of Psychology, University of Waterloo, Waterloo, Canada.
K Michael CummingsDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, United States.
Ron BorlandSchool of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Gary C K ChanNational Centre for Youth Substance Use Research, Faculty of Health and Behavioral Sciences, University of Queensland, Queensland, Australia.
Carmen C W LimNational Centre for Youth Substance Use Research, Faculty of Health and Behavioral Sciences, University of Queensland, Queensland, Australia.
Coral GartnerNHMRC Centre of Research Excellence on Achieving the Tobacco Endgame, Faculty of Medicine, School of Public Health, University of Queensland, Herston, Australia.
Hua-Hie YongSchool of Psychology, Deakin University, Geelong, Victoria, Australia.
Leonie S BroseAddictions Department, King's College London, Addiction Sciences Building, London, United Kingdom.
King's College London · GBThe University of Queensland · AUDeakin University · AUMedical University of South Carolina · USOntario Institute for Cancer Research · CAThe University of Melbourne · AUUniversity of Waterloo · CA

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FONG, GEOFFREY T · 2016 to 2025
$25.3M
Medical Research Council MR/S037519/1NCI NIH HHS P01 CA200512
6 · The paper itself

Abstract

introductionPeople with mental health conditions are disproportionately affected by smoking-related diseases and death. The aim of this study was to assess whether health professional (HP) interactions regarding smoking cessation and nicotine vaping products (NVPs) differ by mental health condition.

methodsThe cross-sectional 2018 International Tobacco Control Four Country (Australia, Canada, England, United States) Smoking and Vaping Survey data included 11040 adults currently smoking or recently quit. Adjusted weighted logistic regressions examined associations between mental health (self-reported current depression and/or anxiety) and visiting a HP in last 18 months; receiving advice to quit smoking; discussing NVPs with a HP; and receiving a recommendation to use NVPs.

resultsOverall, 16.1% self-reported depression and anxiety, 7.6% depression only, and 6.6% anxiety only. Compared with respondents with no depression/anxiety, those with depression (84.7%, AOR=2.65; 95% CI: 2.17-3.27), anxiety (82.2%, AOR=2.08; 95% CI: 1.70-2.57), and depression and anxiety (87.6%, AOR=3.74; 95% CI: 3.19-4.40) were more likely to have visited a HP. Among those who had visited a HP, 47.9% received advice to quit smoking, which was more likely among respondents with depression (AOR=1.58; 95% CI: 1.34-1.86), and NVP discussions were more likely among those with depression and anxiety (AOR=1.63; 95% CI: 1.29-2.06). Of the 6.1% who discussed NVPs, 33.5% received a recommendation to use them, with no difference by mental health.

conclusionsPeople with anxiety and/or depression who smoke were more likely to visit a HP than those without, but only those with depression were more likely to receive cessation advice, and only those with depression and anxiety were more likely to discuss NVPs. There are missed opportunities for HPs to deliver cessation advice. NVP discussions and receiving a positive recommendation to use them were rare overall.

Indexed as

anxietycessation advicecessation supportdepressione-cigarettehealth professional discussionsmental healthquit smokingsmoking cessationvaping products

Identifiers

PMID37533461
PMCPMC10391919
OpenAlexW4385494532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.